Lheureux, Stephanie <br/><br/>
Endometrial cancer-targeted therapies myth or reality? Review of current targeted treatments.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  05 2016 
 - 99-108 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2016.02.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Clinical Trials as Topic<br/>Endometrial Neoplasms--drug therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Humans<br/>MAP Kinase Signaling System--physiology<br/>Metformin--therapeutic use<br/>Molecular Targeted Therapy--methods<br/>Neovascularization, Pathologic--prevention & control<br/>Phosphatidylinositol 3-Kinases--drug effects<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>TOR Serine-Threonine Kinases--metabolism